☆ 4.3 Article

Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biology

Vaccine-induced COVID-19 mimicry syndrome

Eric Kowarz et al.

Summary: A global vaccination campaign is underway to immunize billions of people against the COVID-19 pandemic. However, rare cases of severe side effects, such as cerebral venous sinus thrombosis (CVST), have been reported after vaccination with adenoviral vector-based vaccines. These events have not been observed with mRNA-based vaccines. Scientists have proposed a mechanism called vaccine-induced immune thrombotic thrombocytopenia (VITT) and discovered that DNA-encoded Spike protein can be spliced in a way that leads to the secretion of potentially harmful Spike variants. Avoiding such splicing events is important for the safety of future vaccines.

ELIFE (2022)

添加到收藏夹

Review Immunology

Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia

Natalija Novak et al.

Summary: The development of vaccines for COVID-19 began at the start of the pandemic and four vaccines have been authorized by international agencies. These vaccines have shown a significant decrease in infections and deaths, but rare adverse events have also been reported.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2022)

添加到收藏夹

Article Rheumatology

Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey

Vittorio Pengo et al.

Summary: This nationwide multicenter survey evaluated the course of COVID-19 and adverse events after vaccination in patients with triple-positive thrombotic APS. The results showed that these patients did not suffer from severe COVID-19 outcomes and COVID-19 vaccination was well tolerated. These findings can help reassure patients and physicians and reduce hesitancy in unvaccinated individuals.

RHEUMATOLOGY (2022)

添加到收藏夹

Article Infectious Diseases

The clinical significance of antiphospholipid antibodies in COVID-19 infection

Ebru Atalar et al.

Summary: The increased level of aPLs is associated with the severity of clinical symptoms in COVID-19 patients, but not with critical complications. Therefore, routine examination of aPLs may not be necessary in COVID-19 patients.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2022)

添加到收藏夹

Article Rheumatology

COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study

Haoyu Pan et al.

Summary: The inactivated SARS-CoV-2 vaccine does not affect the levels of autoantibodies in primary APS patients nor induce thrombotic events.

RHEUMATOLOGY (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Thrombosis and Coagulopathy in COVID-19

Juan Esteban Gomez-Mesa et al.

Summary: Since the outbreak of COVID-19 in Wuhan in December 2019, the virus has spread globally, leading to a pandemic declaration by the World Health Organization. Hospitalized patients with severe COVID-19 who have comorbidities and abnormal coagulation function are at higher risk of poor prognosis, while early anticoagulant treatment with low molecular weight heparin has been shown to significantly reduce mortality rates.

CURRENT PROBLEMS IN CARDIOLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine

Giuseppe Carli et al.

INTERNAL AND EMERGENCY MEDICINE (2021)

添加到收藏夹

Letter Respiratory System

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

David M. Smadja et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

添加到收藏夹

Letter Rheumatology

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies

Savino Sciascia et al.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?

Rossella Talotta et al.

Summary: Antiphospholipid antibodies (aPLs), present in 1-5% of healthy individuals, may play a role in the pathogenesis of rare adverse events following COVID-19 vaccination. These antibodies can activate coagulation factors and induce abnormal platelet activation, potentially leading to thrombotic events. Further investigations are warranted to determine the exact association between aPLs and thrombotic events post-vaccination.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort

Tingting Liu et al.

Summary: Research conducted in China indicates that after receiving an inactivated COVID-19 vaccine, there were no significant changes in prothrombotic autoantibody levels or increased risk of thrombosis observed.

SCIENCE BULLETIN (2021)

添加到收藏夹

Article Hematology

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Ning Tang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Critical Care Medicine

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Xiaobo Yang et al.

Lancet Respiratory Medicine (2020)

添加到收藏夹

Article Medicine, General & Internal

Epidemiology of SARS-CoV-2 infection and COVID-19

B. Salzberger et al.

INTERNIST (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature

Ying-Kiat Tan et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

添加到收藏夹

Article Immunology

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

Maria Orietta Borghi et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Review Rheumatology

An update on the management of antiphospholipid syndrome

Mia Rodziewicz et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2020)

添加到收藏夹

Article Hematology

Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine

Mojca Bizjak et al.

SEMINARS IN HEMATOLOGY (2016)

添加到收藏夹

Review Rheumatology

Infections and vaccines in the etiology of antiphospholipid syndrome

Paola Cruz-Tapias et al.

CURRENT OPINION IN RHEUMATOLOGY (2012)

添加到收藏夹

Article Rheumatology

Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome

A. Katzav et al.

LUPUS (2012)

添加到收藏夹

Article Immunology

Murine Monoclonal Antibody 26 Raised Against Tetanus Toxoid Cross-Reacts with beta(2)-Glycoprotein I: Its Characteristics and Role in Molecular Mimicry

Aleksandra Inic-Kanada et al.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)

添加到收藏夹

Review Immunology

Redox-reactive autoantibodies: Detection and physiological relevance

JA McIntyre et al.

AUTOIMMUNITY REVIEWS (2006)

添加到收藏夹

Article Rheumatology

Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin

M Vega-Ostertag et al.

ARTHRITIS AND RHEUMATISM (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.